Comparative Efficacy, Safety, PK, and Immunogenicity Study

Clinical trial NCT05853354 · UNKNOWN

Trial details

NCT number: NCT05853354
Sponsor: Luye Pharma Group Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2023-04-05
Primary completion: 2025-07-30
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.